![](/img/cover-not-exists.png)
Anti-EGFR monoclonal antibodies which act as EGF, TGFα, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours
Helmout Modjtahedi, Toshi Komurasaki, Hitoshi Toyoda, Christopher DeanVolume:
75
Year:
1998
Language:
english
Pages:
7
DOI:
10.1002/(sici)1097-0215(19980119)75:23.0.co;2-f
File:
PDF, 294 KB
english, 1998